My No. 1 "Nuclear Renaissance" Stock Pick for 2025
Bill Gates, Warren Buffett, Elon Musk, and Jeff Bezos Are "Silent Partners" on the Next Phase of A.I. One Little-Known 'Savior Stock' - trading at just $8 right now - Offers a Rare Opportunity to Profit in the NEXT A.I.
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Repligen acquires 908 Devices' desktop portfolio for $70 million, enhancing its bioprocessing analytics. 908 Devices shifts focus to handheld growth, forecasting revenue gains.
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people .
AI Is Stealing From You (Claim up to $41,430 a Year as Payback) - Ad
OpenAI openly states that "your data is used to improve model performance." but it's about time you got paid for that. Luckily, I've found a government-backed income stream that could pay you up to $41,430 a year in "AI equity checks." Best of all, it takes only five minutes and as little as $10 to get started!
Strong Immunoglobulin Reduction Data Positions Biohaven's BHV-1300 As Potential Autoimmune Therapy
Biohaven's BHV-1300 reduced IgG levels by up to 84% in a Phase 1 trial for autoimmune disease, with rapid and sustained effects and a favorable safety profile.
Meet Amy Gleason, the DOGE administrator who may — or may not — be wielding extraordinary power
When her daughter was diagnosed with a rare autoimmune disease in 2010, attacked the challenge.
Is This Elon's True Agenda? - Ad
After you see the new research my Boston think tank just put together...You'll view Elon Musk in a totally new light. It will all suddenly make sense. In fact, it's been building up to what could play out over the next 100 days.
AstraZeneca's Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients
AstraZeneca's Imfinzi perioperative regimen improved event-free survival in gastric and GEJ cancer. The trial showed a strong trend in overall survival.
Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251
Zymeworks shifts focus to ZW251 for liver cancer, delaying ZW220. Q4 revenue and earnings missed estimates. GSK milestone adds $14M to cash reserves.
Strikes and Economic Unrest: Are You Prepared for What's Coming? - Ad
Louis Navellier has issued a chilling warning about the economic turmoil gripping America today. The rapid advancement of artificial intelligence and automation is reshaping industries and posing threats to jobs, pushing America's financial system to its limits. If you're not prepared, it could devastate your savings, investments, and even your retirement.
Tevogen Bio's T-Cell Therapy Approach Stands Out, Analyst Sees Strong Potential
D Boral Capital initiates Buy on Tevogen Bio citing its scalable T-cell therapies and upcoming clinical readouts, with a $10 price target.
Michael Bloomberg tops the list of America’s biggest donors for the second year in a row
For the second year in a row, former New York City mayor Michael Bloomberg gave the most to charitable causes, according to the Chronicle of Philanthropy’s exclusive list of the Americans who donated the largest sums to nonprofits last year.
"Boring Trade" Generates $185 Every Day. Like Clockwork. - Ad
Forget cryptos, pot stocks, and other "shiny object" investments. Instead, you could collect an average of $185 every day of the year with this "boring" trade strategy Forbes magazine says is "like finding money in the street."
Maryland's largest provider for Medicaid enrollees gets its accreditation suspended
ANNAPOLIS, Md. (AP) — Maryland's largest managed care organization for Medicaid enrollees has had its accreditation suspended due to concerns with credentialing and quality reviews for its providers, a state health department official said Friday.
Generic Drugmaker Amneal Clocks Mixed Q4 Earnings, Plans Expansion In High-Growth Areas Like Weight Loss Products, Biosimilars
Amneal Pharmaceuticals' Q4 sales rose 18% to $730.52M, surpassing estimates, while adjusted EPS missed. The company forecasts up to $3.1B in 2025 revenue.
Warning: China Launches AI Attack on America - Ad
China just launched what can only be described as an AI attack on America. And according to Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... President Trump is already planning a counter attack. And it's creating an incredible opportunity for you in this small group of AI stocks.
The number of babies born in South Korea last year rebounded for the first time in nearly a decade
SEOUL, South Korea (AP) — The number of babies born in South Korea rebounded for the first time in nine years in 2024, welcome news for a country grappling with one of the the world’s most serious .
Republican lawmakers look for ways to weaken state judges
TOPEKA, Kansas (AP) — Measures in several state legislatures this year have called for new approaches to weaken the power of judges.
The Same "Magic Pattern" That Predicted Trump's Win Now Predicts These Niche-Trades Will Surge! - Ad
It predicted Trump's sweeping victory. And now, this pattern says a handful of niche-sectors are poised to surge as President Trump fuels America's economic boom. For only $19, you can see how millionaire-trader Jeff Clark has used this "Magic Pattern" for over 40 years to generate over 1,000 winning trade recommendations.
Court Dismisses Novartis Challenge To Medicare Drug Price Negotiation Program
A federal court rejected Novartis' legal challenge to the Medicare Drug Price Negotiation Program, ruling that it does not impose unconstitutional fines, takings, or compelled speech.
In Brazil, mining giant Vale is sued over metal contamination found in Indigenous peoples
BRASILIA, Brazil (AP) — Brazil’s Federal Prosecutor’s Office is suing the giant mining company Vale, the Brazilian government and the Amazon state of Para over heavy metal contamination in the bodies of Xikrin Indigenous people.
Consumer Confidence Nosedives -- Feb Data Confirms Worst AI Fears - Ad
The latest economics numbers just came in, and they're disturbing to say the least! But there's something bigger happening...That's exactly why Dr. Martin D. Weiss, Founder of Weiss Ratings, has outlined 4 critical steps you need to take now before it's too late. The window of opportunity here is very short.
Elizabeth Holmes fails to overturn her Theranos fraud conviction
SAN FRANCISCO (AP) — , the disgraced founder of Theranos, will remain in prison after losing a bid Monday to overturn her , with a federal appeals court saying she hadn’t proved there were legal missteps during her trial for defrauding investors with false claims of what her blood-testing startup could achieve.
Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs
Axsome's Symbravo outperformed oral CGRP inhibitors in a Phase 3 trial, improving migraine pain relief, symptom control, and return to daily activities.
13-Second Trump Video Could Trigger AI Shock - Ad
Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... Just released a video with this 13-second Trump clip about the current AI boom. Please, do NOT buy any AI stock before watching that clip. What President Trump said in that clip could have implications for this AI boom.
Motive in Pennsylvania hospital shooting unclear, but officials say man had recent contact with ICU
YORK, Pa. (AP) — The man who authorities say entered a Pennsylvania hospital with zip ties and a pistol over the weekend had recent contact with the hospital's intensive care unit, where he took staff members hostage and was killed in a shootout that left a police officer dead and others injured.
Measles Cases Surge 5x In US In A Week, CDC Reports: Outbreak Primarily Originating From A Texas County
The U.S. Centers for Disease Control and Prevention (CDC) has reported a dramatic increase in measles cases across the nation.
Nvidia Is About to Shock the World: March 17th - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: March 17th! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments , federal regulators said Friday.
Why Is Penny Stock Aptose Biosciences Trading Higher On Thursday?
Aptose Biosciences advances its Phase 1/2 TUSCANY trial, escalating tuspetinib dosing after a favorable safety review. Enrollment continues across U.S. sites.
A $19 Secret to Potentially Life-Changing Gains - Ad
It predicted Trump's sweeping victory. And now, this pattern says a handful of niche-sectors are poised to surge as President Trump fuels America's economic boom. For only $19, you can see how millionaire-trader Jeff Clark has used this "Magic Pattern" for over 40 years to generate over 1,000 winning trade recommendations.
Is spending all day on your feet at work an occupational hazard?
NEW YORK (AP) — While traveling in Europe, Margaux Lantelme noticed something different about the : they did their work sitting down. It was a stark contrast to Chicago, where Lantelme and cashiers typically spend eight hours a day on their feet.
EU publishes farming sector reform 'vision' which aims to cut red tape and redistribute subsidies
BRUSSELS (AP) — The European Union's executive on Wednesday heeded the call of activist agricultural organizations and the complaints of hard-right parties by proposing a vision for the future of farming and food production that aims to cut deep into the complicated rules designed to protect the environment.
Warning: "The 2025 Tech Meltdown" - Ad
One of the biggest stock market events in 25 years is rapidly unfolding...The chaos is set to begin on May 21st. This is why the world's financial elite are panic-selling stocks at the fastest rate in a decade. So, will you be ready for what's coming?
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
Moderna misses Q4 EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake challenges.
Why Is Walgreens Boots Alliance Stock Trading Higher On Tuesday?
Walgreens is in talks with Sycamore Partners for a potential buyout.
Stocks to Crash on March 16, 2026? Here's Compelling Reason Why - Ad
Perhaps no one on or off Wall Street has been more accurate calling the bull and bear turns of the past 7 years. From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024. And now, Marc Chaikin is predicting the next crash will start March 14, 2026. If you have money in the markets, Chaikin's thesis is a must-see.
Musk's DOGE Under Treasury Scrutiny, Trump's Tariffs Impacting Soda Industry, And More
The past week has been a whirlwind of news, with the spotlight on Elon Musk's DOGE and its access to federal payment systems.
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.